CRIP1 expression is correlated with a favorable outcome and less metastases in osteosarcoma patients

Predicting the clinical course of osteosarcoma patients is a crucial prerequisite for a better treatment stratification in these highly aggressive neoplasms of bone. In search of new and reliable biomarkers we recently identified cysteine-rich intestinal protein 1 (CRIP1) to have significant prognostic impact in gastric cancer and therefore decided to investigate its role also in osteosarcoma. For this purpose we analyzed 223 pretherapeutic and well characterized osteosarcoma samples for their immunohistochemical expression of CRIP1 and correlated our findings with clinico-pathological parameters including follow-up, systemic spread and response to chemotherapy. Interestingly and contrarily to gastric cancer, we found CRIP1 expression more frequently in patients with long-term survival (10-year survival 73% in positive vs. 54% in negative cases, p = 0.0433) and without metastases (p = 0.0108) indicating a favorable prognostic effect. CRIP1 therefore seems to represent a promising new biomarker in osteosarcoma patients which should be considered for a prospective validation.

• Publication year

  2011

• Venue

  OncoTarget

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.18632/ONCOTARGET.398PMID 22202598PMCID 3282102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathology and Genetics of Tumours of Soft Tissue and Bone

  2013cited by this paper
• MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.

  2011cited by this paper
• Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

  2010cited by this paper
• Identification of brain- and bone-specific breast cancer metastasis genes.

  2009cited by this paper
• Biomarkers in Osteosarcoma.

  2009cited by this paper
• Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater

  2009cited by this paper
• Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer

  2007cited by this paper
• Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III

  2006cited by this paper
• Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

  2006cited by this paper
• Genes associated with breast cancer metastatic to bone.

  2006cited by this paper
• Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

  2005cited by this paper
• Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.

  2004cited by this paper
• Morphological grades of regression in osteosarcoma after polychemotherapy — Study COSS 80

  2004cited by this paper
• Gene expression profiles of human breast cancer progression

  2003cited by this paper
• Tissue Microarrays Identification of Cervical Cancer Markers by cDNA and Updated

  2003cited by this paper
• cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells

  2003cited by this paper
• Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

  2002cited by this paper
• Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response.

  2002cited by this paper
• Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.

  2002cited by this paper
• Regulation of cysteine-rich intestinal protein, a zinc finger protein, by mediators of the immune response.

  2000cited by this paper
• Developmental regulation of a gene that encodes a cysteine-rich intestinal protein and maps near the murine immunoglobulin heavy chain locus.

  1986cited by this paper

• CRIP1 knockdown enhances glycolytic dependence and increases sensitivity to 2-Deoxy-D-Glucose in acute myeloid leukemia

  2026cites this paper
• Cysteine-rich intestinal protein family: structural overview, functional diversity, and roles in human disease

  2025cites this paper
• SNAP: Streamlined Nextflow Analysis Pipeline for Immunoprecipitation-Based Epigenomic Profiling of Circulating Chromatin

  2025influential citation
• PRMT1/PRMT5-Mediated Differential Arginine Methylation of CRIP1 Promotes the Recurrence of Small Cell Lung Cancer after Chemotherapy

  2025cites this paper
• CRIP-1 overexpression-prognostic factor in children’s osteosarcoma?

  2024influential citation
• STUDY ON THE OVEREXPRESSION OF IGF1 AND CRIP 1 IN CHILDREN OSTEOSARCOMAS

  2024cites this paper
• A phase 2 study of epacadostat and pembrolizumab in patients with advanced sarcoma.

  2023cites this paper
• CRIP1 supports the growth and migration of AML-M5 subtype cells by activating Wnt/β-catenin pathway.

  2023cites this paper
• CRP‑1 promotes the malignant behavior of hepatocellular carcinoma cells via activating epithelial‑mesenchymal transition and Wnt/β‑catenin signaling

  2023cites this paper
• Molecular Subtyping and Survival Analysis of Osteosarcoma Reveals Prognostic Biomarkers and Key Canonical Pathways

  2023cites this paper
• Single-cell RNA sequencing reveals rebalancing of immunological response in patients with periodontitis after non-surgical periodontal therapy

  2022cites this paper
• Comprehensive Analysis of CRIP1 in Patients with Ovarian Cancer, including ceRNA Network, Immune-Infiltration Pattern, and Clinical Benefit

  2022cites this paper
• Liquid biopsy in bone sarcomas and identification of new biomarkers

  2022cites this paper
• CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy

  2021cites this paper
• Cysteine-Rich Intestinal Protein 1 Served as an Epithelial Ovarian Cancer Marker via Promoting Wnt/β-Catenin-Mediated EMT and Tumour Metastasis

  2021cites this paper
• Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia.

  2020cites this paper
• Identification of potential diagnostic gene biomarkers in patients with osteoarthritis

  2020cites this paper
• Effects of sea-buckthorn leaves on performance and serum metabolic profiles in Altay lambs

  2019cites this paper
• New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions

  2019cites this paper
• Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation

  2019cites this paper
• CRIP1 promotes cell migration, invasion and epithelial‐mesenchymal transition of cervical cancer by activating the Wnt/&bgr;‐catenin signaling pathway

  2018cites this paper
• The Impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) on Thyroid Carcinoma

  2017cites this paper
• CRIP1, a novel immune-related protein, activated by Enterococcus faecalis in porcine gastrointestinal epithelial cells.

  2017cites this paper
• Angiotensin II type 2 receptor signalling promotes glioblastoma growth : a novel target for therapeutic intervention

  2017cites this paper
• Cysteine-Rich Intestinal Protein 1 Silencing Inhibits Migration and Invasion in Human Colorectal Cancer

  2017cites this paper
• Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma

  2017influential citation
• Arginine (Di)methylated Human Leukocyte Antigen Class I Peptides Are Favorably Presented by HLA-B*07.

  2017cites this paper
• High‐grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging

  2016cites this paper
• Integrative analysis of microRNA and mRNA expression profiles in osteosarcoma cell lines

  2016cites this paper
• Differential Regulation of Gene and Protein Expression by Zinc Oxide Nanoparticles in Hen’s Ovarian Granulosa Cells: Specific Roles of Nanoparticles

  2015cites this paper
• Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy

  2015cites this paper
• Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma

  2014cites this paper
• Combining peptide and DNA for protein assay: CRIP1 detection for breast cancer staging.

  2014cites this paper
• miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma

  2014cites this paper
• The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer

  2013cites this paper
• Molekulare Charakterisierung von Osteosarkomen

  2013cites this paper
• MALDI imaging mass spectrometry in clinical proteomics research of gastric cancer tissues

  2012cites this paper
• Targeting JNK-interacting protein 1 (JIP1) sensitises osteosarcoma to doxorubicin

  2012cites this paper
• Digital Commons @ University of South Florida Digital Commons @ University of South Florida

  year unknowncites this paper